Latest Articles about GTIV

Weak 1Q Earnings for Gentiva - Analyst Blog

Zacks Equity Research — Thu, 09 May 2013 19:25:01 Z

Gentiva Health Services Inc. ( GTIV ) reported first-quarter 2013 operating earnings of 23 cents per share, which lagged the Zacks Consensus Estimate of 31 cents as well as the year-ago

Gentiva Downgraded to Strong Sell - Analyst Blog

Zacks Equity Research — Tue, 26 Mar 2013 02:29:38 Z

On Mar 23, 2013, Zacks Investment Research downgraded Gentiva Health Services Inc. ( GTIV ) to a Zacks Rank #5 (Strong Sell). Why the Downgrade? Gentiva has witnessed a downturn in

Gentiva's 2013 Guidance Disappoints - Analyst Blog

Zacks Equity Research — Thu, 21 Mar 2013 17:34:05 Z

Recently, Gentiva Health Services Inc. ( GTIV ) released it financial guidance for 2013. The company expects adjusted income from continuing operations between 90 cents and $1.10 per share,

DaVita Beats in 4Q, Grows Y/Y - Analyst Blog

Zacks Equity Research — Fri, 15 Feb 2013 01:13:01 Z

DaVita HealthCare Partners Inc. ( DVA ) reported fourth-quarter 2012 operating earnings of $1.68 per share, beating the Zacks Consensus Estimate of $1.57 as well as $1.56 per share

Disappointing 4Q for Gentiva - Analyst Blog

Zacks Equity Research — Thu, 07 Feb 2013 23:47:11 Z

Gentiva Health Services Inc. ( GTIV ) reported fourth-quarter 2012 operating earnings of 31 cents per share, which lagged the Zacks Consensus Estimate of 35 cents as well as the year-ago

Gentiva Maintained at Neutral - Analyst Blog

Zacks Equity Research — Thu, 17 Jan 2013 21:30:01 Z

We have reiterated our Neutral recommendation on Gentiva Health Services Inc. ( GTIV ) based on rising expenses, Medicare rate cut and legal hassles, which are expected to weigh on the

Amedisys Beats EPS, Misses Rev - Analyst Blog

Mark Vickery — Wed, 14 Nov 2012 19:30:01 Z

Home healthcare provider Amedisys ( AMED ) reported earnings per share (EPS) of 33 cents in the third quarter of fiscal 2012, comfortably beating the Zacks Consensus Estimate of 27 cents.

Gentiva Beats, Raises 2012 Guidance - Analyst Blog

Zacks Equity Research — Thu, 01 Nov 2012 21:41:01 Z

Gentiva Health Services Inc. ( GTIV ) reported third-quarter 2012 operating net earnings of 32 cents per share, modestly beating the Zacks Consensus Estimate of 29 cents as well as year-ago

Dismal Sales Projection for Amedisys - Analyst Blog

Zacks Equity Research — Wed, 17 Oct 2012 01:53:03 Z

The change in agreement with Humana Inc. ( HUM ) led to a decline in the share prices of Amedisys ( AMED ) - the leading U.S. player in the home health and hospice segment - by 9.38%, to

Gentiva Downgraded to Neutral - Analyst Blog

Zacks Equity Research — Tue, 16 Oct 2012 21:51:30 Z

We are downgrading our recommendation on Gentiva Health Services Inc. ( GTIV ) to 'Neutral' based on increased operating and interest expense burden, and the expected negative impact of

Gentiva Buys Mississippi Hospice - Analyst Blog

Zacks Equity Research — Wed, 12 Sep 2012 21:30:01 Z

Yesterday, Gentiva Health Services Inc. ( GTIV ) announced the acquisition of North Mississippi Hospice for an undisclosed price. While the financial terms of the deal were not divulged,

Gentiva Buys Family Home Care - Analyst Blog

Zacks Equity Research — Thu, 06 Sep 2012 21:30:01 Z

Recently, Gentiva Health Services Inc. ( GTIV ) announced that it has purchased the home health and hospice operations of Washington-based Family Home Care Corporation. The financial terms of

Gentiva Health Services (GTIV) - Bull of the Day

Zacks Equity Research — Mon, 27 Aug 2012 09:00:01 Z

Gentiva Health Services ( GTIV ) was upgraded from Neutral to Outperform based on its strong revenues and strategic acquisitions. The company's second quarter earnings surpassed the Zacks

Gentiva Raised to Outperform - Analyst Blog

Zacks Equity Research — Thu, 23 Aug 2012 20:33:40 Z

We are upgrading our recommendation on Gentiva Health Services Inc. ( GTIV ) to Outperform based on its strong revenues and strategic acquisitions. Furthermore, a reduced debt balance

Linde Closes Lincare Acquisition - Analyst Blog

Zacks Equity Research — Tue, 14 Aug 2012 21:15:01 Z

The Linde Group recently completed its acquisition of Lincare Holdings Inc., a leading provider of oxygen and respiratory therapies. Following the acquisition, Lincare has been incorporated into